(Total Views: 713)
Posted On: 07/13/2020 1:07:45 PM
Post# of 148903
After listening to Podcast The Drive #117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19 I sent Bruce Patterson's manuscript -- Disruption of the CCL5/RANTES-CCR5 Pathway-- https://www.medrxiv.org/content/10.1101/2020....20084673v1 to Dr. Perlman:
I found it interesting that he had already read it, and like a good scientist was cautious and yet open to the fact that CCL5 COULD be the most important target.
Probably more important to us as CYDY bagholders... we have safety data and HOPEFULLY agood blinded study results showing that it works and can be first to market, which is obviously critical to treatment NOW.
He responded with the below.
"Craig,
Thanks for sending this manuscript. I had seen it and I think that it points out the importance of tempering the immune response. However, whether CCL5 is the most critical target is still an open question, I think."
Stanley Perlman, M.D., Ph.D.
Professor
Department of Microbiology
University of Iowa
STANLEY PERLMAN, M.D., PH.D.
Stanley is a professor of microbiology and immunology along with being a professor of pediatrics and the chair of virology at the University of Iowa. Stanley has researched coronaviruses for nearly four decades and his lab is currently using mouse models for SARS-CoV-1 and SARS-CoV-2, to better understand the more severe diseases that affect humans.
Cheers,
Craig/bugeater PharmD
I found it interesting that he had already read it, and like a good scientist was cautious and yet open to the fact that CCL5 COULD be the most important target.
Probably more important to us as CYDY bagholders... we have safety data and HOPEFULLY agood blinded study results showing that it works and can be first to market, which is obviously critical to treatment NOW.
He responded with the below.
"Craig,
Thanks for sending this manuscript. I had seen it and I think that it points out the importance of tempering the immune response. However, whether CCL5 is the most critical target is still an open question, I think."
Stanley Perlman, M.D., Ph.D.
Professor
Department of Microbiology
University of Iowa
STANLEY PERLMAN, M.D., PH.D.
Stanley is a professor of microbiology and immunology along with being a professor of pediatrics and the chair of virology at the University of Iowa. Stanley has researched coronaviruses for nearly four decades and his lab is currently using mouse models for SARS-CoV-1 and SARS-CoV-2, to better understand the more severe diseases that affect humans.
Cheers,
Craig/bugeater PharmD
(2)
(0)Scroll down for more posts ▼
